Fatima Mechta‐Grigoriou

Inserm — France

Immunology and Microbiology · Life Sciences

49h-index20.5kcitations146works14.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(29), Cancer Cells and Metastasis(17), Cancer, Hypoxia, and Metabolism(16), Cancer Immunotherapy and Biomarkers(15), Nanoplatforms for cancer theranostics(12)

Publications142 total

SCANDARE: an institutional dynamic prospective interventional biobanking study
BMC Cancer·2026Open Access
Connecting mitochondrial metabolism and mitotic fidelity to control vulnerability of high grade serous ovarian cancer patients to taxane-based chemotherapy
2026Open Access
An Extracellular Matrix–Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation
Cancer Research·2025· 1 citedOpen Access
Scandare: A Successful, Flexible, Prospective, and Longitudinal Biobank Framework
2025Open Access
Protocol for the biofabrication of immunocompetent tumor-on-chip models from patient solid tumors for assessment of anticancer therapies
STAR Protocols·2025· 3 citedOpen Access
Abstract PS18-02: E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Clinical Cancer Research·2025
Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophages
The Journal of Experimental Medicine·2025· 8 cited
Bioengineering a Patient‐Derived Vascularized Lung Tumor‐on‐Chip Model to Decipher Immunomodulation by the Endothelium
Advanced Healthcare Materials·2025· 3 citedOpen Access
At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets
Clinical Cancer Research·2024· 25 cited
E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma
Modern Pathology·2024· 16 citedOpen Access
THU-220 ATM, guardian of genome integrity, is a new player in NAFLD pathogenesis by modulating mitochondrial metabolism
Journal of Hepatology·2024
Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs
Cell Reports Medicine·2024· 17 citedOpen Access
4MO Neoadjuvant letrozole and palbociclib versus chemotherapy in the NeoPAL study: A translational analysis
ESMO Open·2024Open Access
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
Cell Reports Medicine·2024· 28 citedOpen Access
30P E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
ESMO Open·2024· 1 citedOpen Access
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Nature Communications·2024· 108 citedOpen Access
Abstract 2019: Primary cancer associated fibroblasts increase the chemoresistance of triple negative breast cancer cells by mitochondria metabolic upregulation
Cancer Research·2024· 1 cited
Abstract 6932: Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in desmoplastic small round cell tumors
Cancer Research·2024
Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function
Science Signaling·2024· 22 citedOpen Access
YAP/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancer
Molecular and Cellular Biochemistry·2024· 6 cited
page 1 of 8Next →

Frequent Co-authors

Anne Vincent‐Salomon(16), Yann Kieffer(15), Brigitte Bourachot(9), Géraldine Gentric(8), Moshé Yaniv(8), Floriane Pelon(7), Claire Bonneau(6), Sylvain Baulande(6), Virginie Mieulet(6), Ana Costa(5), Mélissa Cardon(5), Philémon Sirven(5), Ilaria Magagna(4), Anne-Marie Givel(4), Vassili Soumelis(4), Thierry Dubois(4), Didier Meseure(4), Ivan Bièche(4), Elisabetta Marangoni(4), Alix Scholer‐Dahirel(3)